LYT-100 in Post-acute COVID-19 Respiratory Disease

Study Name:
LYT-100 in Post-acute COVID-19 Respiratory Disease

Targeted Disease(s):

Purpose of Study:

To evaluate the safety and efficacy of LYT-100 with post-acute COVID-19 respiratory complications who were treated with, but no longer require mechanical ventilation, extracorporeal membrane oxygenation, non-invasive ventilation (eg CPAP or BiPAP), high-flow nasal oxygen therapy, or combination thereof.

Study Dates:
December 11, 2020 - December 30, 2021

Type of Study:

Study Design:
Controlled Design

Study Location:

Lead Institution:

Funding Source:
Puretech Identifier:

Register for Trial
Freedom From Smoking Clinic
, | Oct 25, 2021
Community Connections: Air Quality & Lung Disease
, | Jan 19, 2022